NCT00983801 2020-10-28
Study of Ixabepilone in Asian Subjects With Unresectable or Metastatic Gastric Cancer
R-Pharm
Phase 2 Completed
Clinical Trials
7 trialsNCT00383149 2016-03-10
A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer
R-Pharm
Phase 2 Completed
NCT00023946 2014-05-14
BMS-247550 in Treating Patients With Liver or Gallbladder Cancer
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00022477 2013-09-05
BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer
University of Chicago
Phase 2 Completed
NCT00033306 2013-08-05
BMS-247550 in Treating Patients With Metastatic Colorectal Cancer
University of Alabama at Birmingham
Phase 2 Terminated
NCT00016965 2013-06-24
BMS-247550 in Treating Patients With Advanced Pancreatic Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00017056 2013-06-18
BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy
Memorial Sloan Kettering Cancer Center
Phase 2 Completed